Dublin, April 17, 2017 -- Research and Markets has announced the addition of the "Quantitative Immunoassay Life Science Dashboard Series 3" report to their offering.
Immunoassays are commonly used laboratory tests for identification and quantification of proteins. With a range of applications in diagnosis of cancer, immunology and disease research, immunoassays are widely used by scientists in academia and industry.
The 2016 Quantitative Immunoassay Dashboard is the third in a series that characterizes the dynamic market for immunoassay products.
This 2016 Dashboard provides a snapshot of the current market landscape that is compared with data from all of the previous Quantitative Immunoassay Dashboards , and was developed from responses to a 48-question survey completed by 592 scientists located in North America and Europe.
This Dashboard reveals key market indicators for the Quantitative Immunoassay market as a whole as well as for the following techniques representing market sub-segments:
- Colorimetric ELISA
- Chemiluminescent ELISA
- Fluorescent ELISA
- Electrochemiluminescence immunoassays
- Bead-based immunoassays
- This report is focused on the use of Quantitative Immunoassay products in life science research market.
The following suppliers were surveyed for this report:
- Abcam
- Affymetrix/eBioscience
- BD Biosciences
- Bio-Rad
- GE Healthcare/Amersham
- KPL/SeraCare
- Luminex (direct)
- Meso Scale Discovery
- Perkin Elmer
- R&D Systems/Biotechne
- Roche Applied Science
- Sigma/EMD Millipore
- Thermo Fisher Scientific (including Life Technologies, Pierce, Invitrogen, Novex, Molecular Probes)
Key Topics Covered:
1. Executive Summary
2. Dashboard "At A Glance"
3. Market Opportunity Matrix
4. Respondent Qualification
5. Demographics
6. Frequency of Performance: Life Science Techniques
7. Frequency of Use: Immunoassay Methods & Additional Protein Related Method
8. Co-Performance: Quantitative Immunoassay Methods & Life Science Techniques
9. Throughput, Growth Rates, Price & Monthly Spend
10. Market Size
11. Percentage of Spend with Suppliers of Immunoassay Products
12. Customer Satisfaction & Interest in Switching
13. Product Feature Influencing Purchase Decisions
14. Primary Focus/Application of Protein Analysis Research & Use of Protein Classes/Categories
15. Desired Changes to Immunoassay Products
16. Appendix I: Supporting Data
17. Appendix II: The Capabilities and Life Science Dashboards TM Available
Companies Mentioned
- Abcam
- Affymetrix/eBioscience
- BD Biosciences
- Bio-Rad
- GE Healthcare/Amersham
- KPL/SeraCare
- Luminex (direct)
- Meso Scale Discovery
- Perkin Elmer
- R&D Systems/Biotechne
- Roche Applied Science
- Sigma/EMD Millipore
- Thermo Fisher Scientific (including Life Technologies, Pierce, Invitrogen, Novex, Molecular Probes)
For more information about this report visit http://www.researchandmarkets.com/research/ds2x4b/quantitative
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Biotechnology, In Vitro Diagnostics


Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Instagram Outage Disrupts Thousands of U.S. Users
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 



